{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:26:21Z","timestamp":1794047181651,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114410","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:03:25Z","timestamp":1763373805000},"page":"114410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Controlled delivery of STING agonist and manganese ion in injectable PLGA implants for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"389","author":[{"given":"Swetha","family":"Kodamasimham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen H.","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Haggag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Salamevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Schwendeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2025.114410_bb0005","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminoncol.2015.10.002","article-title":"Immunotherapy combinations with checkpoint inhibitors in metastatic melanoma: current approaches and future directions","volume":"42","author":"Atkins","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114410_bb0015","first-page":"451","article-title":"Immune checkpoint inhibitors: breakthroughs in cancer treatment","volume":"21","author":"Kong","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2025.114410_bb0020","doi-asserted-by":"crossref","first-page":"2169531","DOI":"10.1080\/21645515.2023.2169531","article-title":"Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: a systematic evaluation and meta-analysis","volume":"19","author":"Lu","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.114410_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194616","article-title":"Mechanisms of primary and acquired resistance to immune checkpoint inhibitors in patients with hepatocellular carcinoma","volume":"14","author":"De Lorenzo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2025.114410_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114410_bb0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.coi.2013.02.009","article-title":"Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment","volume":"25","author":"Gajewski","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0040","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114410_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103323","article-title":"Challenges and opportunities in the clinical development of STING agonists for Cancer immunotherapy","volume":"9","author":"Motedayen Aval","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2025.114410_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112695","article-title":"STING agonists as Cancer therapeutics","volume":"13","author":"Amouzegar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2025.114410_bb0055","doi-asserted-by":"crossref","first-page":"1485546","DOI":"10.3389\/fimmu.2024.1485546","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0060","doi-asserted-by":"crossref","first-page":"1777624","DOI":"10.1080\/2162402X.2020.1777624","article-title":"Trial watch: STING agonists in cancer therapy","volume":"9","author":"Le Naour","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2025.114410_bb0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2019.09.089","article-title":"Magnitude of therapeutic STING activation determines CD8(+) T cell-mediated anti-tumor immunity","volume":"29","author":"Sivick","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114410_bb0070","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdt433","article-title":"Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review","volume":"25","author":"Puts","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6606","article-title":"Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114410_bb0080","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","article-title":"Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses","volume":"48","author":"Wang","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114410_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/71916","article-title":"Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)","volume":"18","author":"Zhu","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2025.114410_bb0100","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.drudis.2019.05.013","article-title":"Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application","volume":"24","author":"Simoes","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.114410_bb0105","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1038\/s41598-023-42923-3","article-title":"Influence of drug and polymer molecular weight on release kinetics from HEMA and HPMA hydrogels","volume":"13","author":"Toews","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114410_bb0110","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jconrel.2013.08.295","article-title":"The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides","volume":"172","author":"Sophocleous","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114410_bb0115","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/acs.biomac.0c00885","article-title":"Characterization of octreotide-PLGA binding by isothermal titration calorimetry","volume":"21","author":"Hong","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.114410_bb0120","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/s41467-022-30813-7","article-title":"Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid)","volume":"13","author":"Giles","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114410_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-kappaB that mediate immune defense against tumors and viral infections","volume":"118","author":"Yum","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114410_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008026","article-title":"Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114410_bb0135","doi-asserted-by":"crossref","first-page":"eadi3487","DOI":"10.1126\/sciimmunol.adi3487","article-title":"Expansion of tumor-reactive CD8(+) T cell clonotypes occurs in the spleen in response to immune checkpoint blockade","volume":"9","author":"Morgan","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0140","doi-asserted-by":"crossref","first-page":"1488345","DOI":"10.3389\/fimmu.2024.1488345","article-title":"Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy","volume":"15","author":"Qi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.jconrel.2025.114410_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2025.114410_bb0155","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.biomaterials.2012.03.041","article-title":"Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype","volume":"33","author":"Demento","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114410_bb0160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0264-410X(01)00444-3","article-title":"Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses","volume":"20","author":"Kemp","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114410_bb0165","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41551-024-01221-7","article-title":"Strategies for the development of metalloimmunotherapies","volume":"8","author":"Sun","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114410_bb0170","series-title":"Multicenter Study of MK-1454 Administered by Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab for Patients With Advanced\/Metastatic Solid Tumors or Lymphomas, in","author":"Phase 1 Open-label","year":"2017"},{"key":"10.1016\/j.jconrel.2025.114410_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2024.07.023","article-title":"Enhancing pancreatic cancer immunotherapy: leveraging localized delivery strategies through the use of implantable devices and scaffolds","volume":"373","author":"Minaei","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114410_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030614","article-title":"Challenges and complications of poly(lactic-co-glycolic acid)-based long-acting drug product development","volume":"14","author":"Lim","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114410_bb0185","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijpharm.2016.01.020","article-title":"Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges","volume":"499","author":"Ramazani","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114410_bb0190","doi-asserted-by":"crossref","first-page":"1807616","DOI":"10.1002\/adfm.201807616","article-title":"Viromimetic STING agonist-loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus","volume":"29","author":"Lin","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.114410_bb0195","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1021\/acs.nanolett.1c03243","article-title":"Engineered Nanovaccine targeting Clec9a(+) dendritic cells remarkably enhances the Cancer immunotherapy effects of STING agonist","volume":"21","author":"Gou","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114410_bb0200","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/acs.molpharmaceut.8b00579","article-title":"Acetalated dextran microparticles for Codelivery of STING and TLR7\/8 agonists","volume":"15","author":"Collier","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114410_bb0205","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jconrel.2021.01.036","article-title":"Maintaining manganese in tumor to activate cGAS-STING pathway evokes a robust abscopal anti-tumor effect","volume":"331","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114410_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041276","article-title":"The influence of shape parameters on unidirectional drug release from 3D printed implants and prediction of release from implants with individualized shapes","volume":"15","author":"Domsta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114410_bb0215","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jps.21038","article-title":"Polymer implants for intratumoral drug delivery and cancer therapy","volume":"97","author":"Weinberg","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114410_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2012.03.031","article-title":"Tumor recurrence after complete resection for non-small cell lung cancer","volume":"93","author":"Taylor","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jconrel.2025.114410_bb0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41571-019-0319-9","article-title":"Harnessing cancer immunotherapy during the unexploited immediate perioperative period","volume":"17","author":"Matzner","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0230","doi-asserted-by":"crossref","first-page":"1344272","DOI":"10.3389\/fimmu.2024.1344272","article-title":"Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0235","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s00262-022-03220-6","article-title":"Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer","volume":"71","author":"Lee","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2025.114410_bb0240","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12903-021-01813-8","article-title":"Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma","volume":"21","author":"Zhu","year":"2021","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.jconrel.2025.114410_bb0245","doi-asserted-by":"crossref","first-page":"1383978","DOI":"10.3389\/fimmu.2024.1383978","article-title":"Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application","volume":"15","author":"Zheng","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114410_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4049\/jimmunol.1601145","article-title":"Intratumoral delivery of immunotherapy-act locally, think globally","volume":"198","author":"Aznar","year":"2017","journal-title":"J. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:44:19Z","timestamp":1794044659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925010247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0168365925010247"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114410","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled delivery of STING agonist and manganese ion in injectable PLGA implants for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114410"}}